| Old Articles: <Older 8171-8180 Newer> |
|---|
 |
The Motley Fool
December 28, 2011
Brian Stoffel |
2011: The Year This Biotech Was Told to Share Procurement of smallpox vaccine has its ups and downs for SIGA Technologies.   |
The Motley Fool
December 28, 2011
Brian Stoffel |
I'm Buying This Stock Right Now MAKO Surgical beats out Baidu and IPG Photonics as my buy for my retirement portfolio. |
The Motley Fool
December 28, 2011
Brian Orelli |
Biotech Post-Holiday Regifting A pair of biotechs were on the receiving end of some holiday jeers today as their pharma partners appear to be uninterested in the drugs they were given. |
The Motley Fool
December 27, 2011
Brian Orelli |
2011 No Dreamboat for MannKind An FDA rejection and a long wait is a bad combination. |
The Motley Fool
December 27, 2011
Brian Orelli |
Exelixis 2011: Not What the Doctor Ordered A tale of an inability to get a Special Protocol Assessment from the FDA. |
The Motley Fool
December 24, 2011
Stephanie Baum |
Johnson & Johnson Recalls Motrin From Retailers It's the sixth recall of Motrin in two years. |
The Motley Fool
December 23, 2011
Brian Orelli |
Geron's Hurry-Up-and-Wait Strategy Clinical trials started, now the waiting begins. |
The Motley Fool
December 23, 2011
Brian Stoffel |
A No-Good, Really Bad, Awful Year for This Pharmaceutical Company CEO's outrageous pricing guides K-V Pharmaceutical down in 2011. |
The Motley Fool
December 23, 2011
Selena Maranjian |
3 Biotech Stocks That Had a Bad 2011 It's a volatile business, and these biotechs got the short end of the stick. |
Chemistry World
December 22, 2011
Sarah Houlton |
Pharma braces for patent cliff impact It remains to be seen quite how far Lipitor sales will fall. Ranbaxy has six months of exclusivity for generic competition. |
| <Older 8171-8180 Newer> Return to current articles. |
